Chemours Co (CC) stock
CCNYSEChemicals & Allied ProductsFiscal year ends December 31
$12.09−0.09 (-0.74%)
Close on Nov 18, 2026Market cap $1.82BP/E –Yield 4.24%
Chemours free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Chemours's free cash flow for the twelve months ending Jun 30, 2026 was $218.00M. For fiscal 2025 it was $51.00M. The highest annual figure on record is $642.00M in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.00M | – |
| FY2024 | Dec 31, 2024 | -$993.00M | -633.9% |
| FY2023 | Dec 31, 2023 | $186.00M | -58.5% |
| FY2022 | Dec 31, 2022 | $448.00M | -16.6% |
| FY2021 | Dec 31, 2021 | $537.00M | -0.6% |
| FY2020 | Dec 31, 2020 | $540.00M | +219.5% |
| FY2019 | Dec 31, 2019 | $169.00M | -73.7% |
| FY2018 | Dec 31, 2018 | $642.00M | +180.3% |
| FY2017 | Dec 31, 2017 | $229.00M | -10.5% |
| FY2016 | Dec 31, 2016 | $256.00M | – |
| FY2015 | Dec 31, 2015 | -$337.00M | – |
| FY2014 | Dec 31, 2014 | -$99.00M | -127.5% |
| FY2013 | Dec 31, 2013 | $360.00M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $114.00M | +128.0% |
| Q1 FY2026 | Mar 31, 2026 | -$93.00M | – |
| Q4 FY2025 | Dec 31, 2025 | $92.00M | +217.2% |
| Q3 FY2025 | Sep 30, 2025 | $105.00M | +66.7% |
| Q2 FY2025 | Jun 30, 2025 | $50.00M | – |
| Q1 FY2025 | Mar 31, 2025 | -$196.00M | – |
| Q4 FY2024 | Dec 31, 2024 | $29.00M | -91.6% |
| Q3 FY2024 | Sep 30, 2024 | $63.00M | +40.0% |
| Q2 FY2024 | Jun 30, 2024 | -$693.00M | -7800.0% |
| Q1 FY2024 | Mar 31, 2024 | -$392.00M | – |
| Q4 FY2023 | Dec 31, 2023 | $347.00M | +269.1% |
| Q3 FY2023 | Sep 30, 2023 | $45.00M | -80.3% |
| Q2 FY2023 | Jun 30, 2023 | $9.00M | -96.1% |
| Q1 FY2023 | Mar 31, 2023 | -$215.00M | – |
| Q4 FY2022 | Dec 31, 2022 | $94.00M | -24.8% |
| Q3 FY2022 | Sep 30, 2022 | $229.00M | -6.1% |
| Q2 FY2022 | Jun 30, 2022 | $229.00M | +21.2% |
| Q1 FY2022 | Mar 31, 2022 | -$104.00M | – |
| Q4 FY2021 | Dec 31, 2021 | $125.00M | -58.3% |
| Q3 FY2021 | Sep 30, 2021 | $244.00M | -3.2% |
| Q2 FY2021 | Jun 30, 2021 | $189.00M | +278.0% |
| Q1 FY2021 | Mar 31, 2021 | -$21.00M | – |
| Q4 FY2020 | Dec 31, 2020 | $300.00M | -1.3% |
| Q3 FY2020 | Sep 30, 2020 | $252.00M | +57.5% |
| Q2 FY2020 | Jun 30, 2020 | $50.00M | – |
| Q1 FY2020 | Mar 31, 2020 | -$62.00M | – |
| Q4 FY2019 | Dec 31, 2019 | $304.00M | +189.5% |
| Q3 FY2019 | Sep 30, 2019 | $160.00M | -29.2% |
| Q2 FY2019 | Jun 30, 2019 | -$118.00M | -154.4% |
| Q1 FY2019 | Mar 31, 2019 | -$177.00M | -288.3% |
| Q4 FY2018 | Dec 31, 2018 | $105.00M | -23.9% |
| Q3 FY2018 | Sep 30, 2018 | $226.00M | +5550.0% |
| Q2 FY2018 | Jun 30, 2018 | $217.00M | +88.7% |
| Q1 FY2018 | Mar 31, 2018 | $94.00M | – |
| Q4 FY2017 | Dec 31, 2017 | $138.00M | -17.4% |
| Q3 FY2017 | Sep 30, 2017 | $4.00M | -96.9% |
| Q2 FY2017 | Jun 30, 2017 | $115.00M | – |
| Q1 FY2017 | Mar 31, 2017 | -$28.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $167.00M | – |
| Q3 FY2016 | Sep 30, 2016 | $131.00M | – |
See a number that looks wrong?